抗小鼠CD8a单抗（克隆号2.43）引用文献
抗小鼠CD8a单克隆抗体（克隆号2.43）引用文献如下：
1. CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
2. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice
3. Antipodoplanin antibody enhances the antitumor effects of CTLA‐4 blockade against malignant mesothelioma by natural killer cells
4.OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
5.Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
6.Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy
7.A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
8.Targeting pathogenic CD8+ tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis
9.A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells
10.Sensory nerves impede the formation of tertiary lymphoid structures and development of protective anti-melanoma immune responses
11.Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
12.FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
13.Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+ T-cell responses and immune memory
14.Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
15.Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
16.Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion
17.Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma
18.Mice with FVB-derived sequence on chromosome 17 succumb to disseminated virus infection due to aberrant NK cell and T cell responses
19.A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma
20.Binary outcomes of enhancer activity underlie stable random monoallelic expression
……
Syd Labs抗小鼠CD8a重组抗体（克隆号2.43）：
Syd Labs 重组抗小鼠CD8a单克隆抗体（克隆号2.43），大鼠IgG2b Kappa，体内实验级（In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone 2.43), Rat IgG2b Kappa，货号：PA007167.r2b）是用哺乳动物细胞生产的重组抗体，从大鼠抗小鼠CD8a单克隆抗体(克隆号:2.43)可变区序列中提取，可用于蛋白质印迹、免疫组织化学（IHC）、流式细胞术（FC）和体内CD8+T细胞耗竭（消耗）等研究。
如果需要了解更多有关Syd Labs 重组抗小鼠CD8a单抗(克隆号2.43)信息，比如Syd Labs 抗小鼠CD8a单抗使用说明等资料，欢迎联系多找找获取。
特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。